牛源A型多杀性巴氏杆菌hyaD基因缺失株的构建及其在小鼠上的交叉保护性分析

doi:10.11843/j.issn.0366-6964.2022.10.030

摘要/Abstract

摘要： hyaD为A型多杀性巴氏杆菌荚膜多糖合成相关基因，为探讨该基因对多杀性巴氏杆菌毒力及其免疫保护特性的影响，本研究利用同源重组方法，构建了牛源A型多杀性巴氏杆菌CQ2株（PmCQ2）的hyaD基因缺失株（ΔhyaD）。结果发现，与野生株相比，ΔhyaD的荚膜产生量及其感染后在脏器中的细菌定殖量均显著下降，其毒力显著降低。细胞试验发现，ΔhyaD更易黏附于巨噬细胞，被吞噬数量显著多于野生株，致使巨噬细胞相关炎性因子表达显著上调。hyaD基因的缺失，可调控与荚膜合成、LPS合成转运、铁转运等相关的基因表达显著下调，促使相关保护性抗原基因表达显著上调。以制备的PmCQ2株和ΔhyaD株灭活苗免疫小鼠（加强免疫1次），免疫后第21天分别采用同源和异源多杀性巴氏杆菌攻毒，ΔhyaD株免疫小鼠肺组织感染后24 h无明显或轻微病理损伤，对牛源A型、B型和F型多杀性巴氏杆菌的免疫保护率分别为100%、100%和80%，对兔源、猪源和禽源A型多杀性巴氏杆菌的免疫保护率分别为90%、100%、100%；而野生株PmCQ2除对牛源A型多杀性巴氏杆菌的保护率在80%以上外，对牛源B型和F型及兔、猪、禽源A型多杀性巴氏杆菌均无明显交叉保护作用。研究结果表明，hyaD基因可通过调控荚膜产生及毒力相关因子表达影响菌株毒力；hyaD基因缺失可调控相关交叉保护性抗原表达，赋予菌株交叉免疫保护特性。该研究为多杀性巴氏杆菌通用型疫苗的研发提供了参考。

关键词: 多杀性巴氏杆菌, hyaD, 基因缺失株, 毒力, 交叉保护性

Abstract: hyaD is a gene involved in capsular polysaccharide synthesis of Pasteurella multocida type A. To investigate the effect of hyaD gene on P. multocida virulence and immune protection characteristics, an hyaD mutant (ΔhyaD) derived from bovine P. multocida type A strain CQ2 (PmCQ2) was constructed by homologous recombination. The results showed that, compared to the wild type strain, the capsule production and virulence of ΔhyaD were significantly reduced, and the bacterial loads in the mice organs infected with ΔhyaD were also decreased. The mutant strains were easier to adhere to mice peritoneal macrophage and were easily been swallowed, leading to the up-regulation of the expression of related inflammatory factors in macrophage. The hyaD gene deletion significantly down-regulated the expression of genes involved in capsule synthesis, LPS synthesis and transport, and iron transport. While significantly up-regulated the expression of protective antigen genes. The inactivated bacterin of wild type PmCQ2 and ΔhyaD strains were prepared by conventional methods, and the mice were immunized with both bacterin, respectively (one booster following the primary immunization). On the day 21 after first immunization, the immunized mice were challenged with homologous and heterologous serotypes P. multocida, the lungs of mice immunized with ΔhyaD had none or slight histopathological lesion at 24 h after challenged. Immunization of mice with ΔhyaD conferred significant protection against challenge from bovine P. multocida type A, type B and type F strains, as well as rabbit, porcine and avian P. multocida type A strains, with protection rate at 100%, 100%, 80%, 90%, 100%, and 100%, respectively; While immunization with similar doses of killed wild-type was failed to confer protections against heterologous and homologous serotypes excepting bovine P. multocida type A strains challenge, with protection rate above 80%. Taken together, the results show that the hyaD gene can affect the virulence of P. multocida by regulating capsule production and expression of virulence-related factors, and the hyaD gene deletion endows mutant cross-protection characteristics by up-regulating the expression of cross-protective antigens, and the mutant can be used as a candidate for the development of P. multocida vaccine. This study lays the foundation for the development of a universal vaccine against P. multocida infection.

Key words: Pasteurella multocida, hyaD, mutant, virulence, cross-protection

中图分类号:

S852.612

杨洋, 谢黎卿, 胡沛, 高丽旭, 袁祥, 李攀, 彭远义, 李能章. 牛源A型多杀性巴氏杆菌hyaD基因缺失株的构建及其在小鼠上的交叉保护性分析[J]. 畜牧兽医学报, 2022, 53(10): 3582-3597.

YANG Yang, XIE Liqing, HU Pei, GAO Lixu, YUAN Xiang, LI Pan, PENG Yuanyi, LI Nengzhang. Construction of Bovine Pasteurella multocida Type A hyaD Mutant and Its Cross-protection Analysis in Mice[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(10): 3582-3597.

参考文献 36

[1]	KUBATZKY K F.Pasteurella multocida and immune cells[M]//AKTORIES K, ORTH H C, ADLER B.Pasteurella Multocida.Berlin:Springer, 2012:53-72.
[2]	SMITH E, MILLER E, AGUAYO J M, et al.Genomic diversity and molecular epidemiology of Pasteurella multocida[J].PLoS One, 2021, 16(4):e0249138.
[3]	TURNI C, SINGH R, BLACKALL P J.Genotypic diversity of Pasteurella multocida isolates from pigs and poultry in Australia[J].Aust Vet J, 2018, 96(10):390-394.
[4]	ORYNBAYEV M, SULTANKULOVA K, SANSYZBAY A, et al.Biological characterization of Pasteurella multocida present in the Saiga population[J].BMC Microbiol, 2019, 19(1):37.
[5]	LI Z C, CHENG F J, LAN S M, et al.Investigation of genetic diversity and epidemiological characteristics of Pasteurella multocida isolates from poultry in southwest china by population structure, multi-locus sequence typing and virulence-associated gene profile analysis[J].J Vet Med Sci, 2018, 80(6):921-929.
[6]	PATEL H, PATEL N, PATEL H, et al.A bite difficult to heal:Pasteurella multocida induced decompensated hepatic cirrhosis[J].J Community Hosp Intern Med Perspect, 2021, 11(3):379-383.
[7]	AMAT S, BAINES D, TIMSIT E, et al.Essential oils inhibit the bovine respiratory pathogens Mannheimia haemolytica, Pasteurella multocida and Histophilus somni and have limited effects on commensal bacteria and turbinate cells in vitro[J].J Appl Microbiol, 2019, 126(6):1668-1682.
[8]	WILSON B A, HO M.Pasteurella multocida:From zoonosis to cellular microbiology[J].Clin Microbiol Rev, 2013, 26(3):631-655.
[9]	CARTER G R.Serological classification of Pasteurella multocida[J].Vet Rec, 1987, 121(16):382-383.
[10]	HARPER M, COX A D, ADLER B, et al.Pasteurella multocida lipopolysaccharide:The long and the short of it[J].Vet Microbiol, 2011, 153(1-2):109-115.
[11]	姜志刚, 徐和敏, 邵葳, 等.牛多杀性巴氏杆菌病二价灭活疫苗的研究[J].中国预防兽医学报, 2019, 41(3):295-299.JIANG Z G, XU H M, SHAO W, et al.Development of bovine Pasteurella multocida bivalent inactivated vaccine[J].Chinese Journal of Preventive Veterinary Medicine, 2019, 41(3):295-299.(in Chinese)
[12]	HOMCHAMPA P, STRUGNELL R A, ADLER B.Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida[J].Vaccine, 1997, 15(2):203-208.
[13]	BOYCE J D, ADLER B.Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis[J].Infect Immun, 2001, 69(3):1943-1946.
[14]	PENG Z, WANG H N, LIANG W, et al.A capsule/lipopolysaccharide/MLST genotype D/L6/ST11 of Pasteurella multocida is likely to be strongly associated with swine respiratory disease in China[J].Arch Microbiol, 2018, 200(1):107-118.
[15]	CHUNG J Y, WILKIE I, BOYCE J D, et al.Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A[J].Infect Immun, 2001, 69(4):2487-2492.
[16]	GUAN L, XUE Y, DING W, et al. Biosynthesis and regulation mechanisms of the Pasteurella multocida capsule[J]. Res Vet Sci, 2019, 127:82-90.
[17]	ASKI H S, TABATABAEI M.Occurrence of virulence-associated genes in Pasteurella multocida isolates obtained from different hosts[J].Microb Pathog, 2016, 96:52-57.
[18]	WILKIE I W, HARPER M, BOYCE J D, et al.Pasteurella multocida:Diseases and pathogenesis[J].Curr Top Microbial Immunol, 2012, 36(1):1-22.
[19]	TATUM F M, YERSIN A G, BRIGGS R E.Construction and virulence of a Pasteurella multocida fhaB2 mutant in turkeys[J].Microb Pathog, 2005, 39(1-2):9-17.
[20]	DU H H, WU C L, LI C M, et al.Two novel cross-protective antigens for bovine Pasteurella multocida[J].Mol Med Rep, 2017, 16(6):4627-4633.
[21]	吕芬芬, 马晓慧, 汪丽, 等.马链球菌马亚种3种抗原蛋白对小鼠免疫的免疫原性分析[J].畜牧兽医学报, 2021, 52(3):752-762.LV F F, MA X H, WANG L, et al.Immunogenicity analysis of three different antigen proteins of Streptococcus equi in mice[J].Acta Veterinaria et Zootechnica Sinica, 2021, 52(3):752-762.(in Chinese)
[22]	JIN H, ZHOU R, KANG M S, et al.Biofilm formation by field isolates and reference strains of Haemophilus parasuis[J].Vet Microbiol, 2006, 118(1-2):117-123.
[23]	HE F, QIN X B, XU N, et al.Pasteurella multocida pm0442 affects virulence gene expression and targets TLR2 to induce inflammatory responses[J].Front Microbiol, 2020, 11:1972.
[24]	YANG Y, HU P, GAO L, et al. Deleting qseC downregulates virulence and promotes cross-protection in Pasteurella multocida[J]. Vet Res, 2021, 52:140.
[25]	PETRUZZI B, BRIGGS R E, TATUM F M, et al.Capsular polysaccharide interferes with biofilm formation by Pasteurella multocida serogroup A[J].mBio, 2017, 8(6):e01843-17.
[26]	VARINRAK T, POOLPERM P, SAWADA T, et al.Cross-protection conferred by immunization with an rOmpH-based intranasal fowl cholera vaccine[J].Avian Pathol, 2017, 46(5):515-525.
[27]	WU J R, SHIEN J H, SHIEH H K, et al.Protective immunity conferred by recombinant Pasteurella multocida lipoprotein e (PlpE)[J].Vaccine, 2007, 25(21):4140-4148.
[28]	LIPSCOMB M F, HUTT J, LOVCHIK J, et al.The pathogenesis of acute pulmonary viral and bacterial infections:Investigations in animal models[J].Annu Rev Pathol, 2010, 5:223-252.
[29]	Al-HASANI K, BOYCE J, MCCARL V P, et al.Identification of novel immunogens in Pasteurella multocida[J].Microb Cell Fact, 2007, 6(1):3.
[30]	VU-KHAC H, TRINH T T H, NGUYEN T T G, et al.Prevalence of virulence factor, antibiotic resistance, and serotype genes of Pasteurella multocida strains isolated from pigs in Vietnam[J].Vet World, 2020, 13(5):896-904.
[31]	TABATABAI L B, ZEHR E S.Identification of five outer membrane-associated proteins among cross-protective factor proteins of Pasteurella multocida[J].Infect Immun, 2004, 72(2):1195-1198.
[32]	LEE J M, KIM Y B, KWON M S.Outer membrane protein H for protective immunity against Pasteurella multocida[J].J Microbiol, 2007, 45(2):179-184.
[33]	KUMAR A, YOGISHARADHYA R, RAMAKRISHNAN M A, et al.Structural analysis and cross-protective efficacy of recombinant 87 kda outer membrane protein (Omp87) of Pasteurella multocida serogroup B:2[J].Microb Pathog, 2013, 65:48-56.
[34]	GARRIDO M E, BOSCH M, BIGAS A, et al.Heterologous protective immunization elicited in mice by Pasteurella multocida fur OmpH[J].Int Microbiol, 2008, 11(1):17-24.
[35]	LI N Z, FENG T, WANG Y L, et al.A single point mutation in the hyaC gene affects Pasteurella multocida serovar A capsule production and virulence[J].Microb Pathog, 2021, 159:105145.
[36]	MOHANTY N N, YOGISHARADHYA R, SHIVACHANDRA S B.Immunogenicity of recombinant outer membrane protein (OmpW) of Pasteurella multocida serogroup B:2 in mouse model[J].Indian J Anim Sci, 2019, 89(10):1073-1077.